COEP
Coeptis Therapeutics Holdings Inc. Common Stock
FINANCE SERVICES
Best Finance Services Stocks 2026 →
Coeptis Therapeutics (COEP) Stock: Buy, Sell, or Hold?
$16.40
+0.19 (+1.17%)
â˛
5d:
+11.95%
30d:
+46.56%
90d:
+17.14%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (71%)
Quality Score
41/100
Position
FAIR
Wall Street Target
$3.00
-81.7% vs target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$11.51 / $17.27
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: COEP is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When COEP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: COEP is currently trading at $16.40, which is considered fair based on recent price action.
Technical Outlook: Technically, COEP is in a downtrend. Immediate support is located at $11.51, while resistance sits at $17.27.
Market Sentiment: COEP scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $3.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, COEP is in a downtrend. Immediate support is located at $11.51, while resistance sits at $17.27.
Market Sentiment: COEP scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $3.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
41/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
71.1%
Trading Range & Key Levels
Support Level
$11.51
Resistance Level
$17.27
Current Trend
Downtrend
Technical data as of
Apr 24, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BEARISH: Trading 81.7% above Wall St target ($3.00)
- WARNING: Composite score 41/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Wall Street Target
$3.00
(-81.7%)
Revenue Growth (YoY)
1563.7%
Share COEP Analysis
Share this live COEP analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (COEP)
Bullish
6 Retail Mentions
StockTwits Volume
6 msgs
24h retail stream
Last Tracked
Apr 27, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate bullish sentiment among traders regarding $COEP merger with $ZSQR, halted since 4am with no official news release yet.
Key Retail Themes:
Merger news
Trader excitement
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:34 PM ET
Data refreshes hourly during market hours. Next update: 6:34 PM
Data refreshes hourly during market hours. Next update: 6:34 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COEP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
28 analysts |
$91 | 54 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 45 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 42 HOLD |
|
RAPP
Rapport Therapeutics, InâĻ |
STRONG BUY
16 analysts |
$64 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive COEP Research Pages
